These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15904908)

  • 41. Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus Patients.
    Askoura M; Abbas HA; Al Sadoun H; Abdulaal WH; Abu Lila AS; Almansour K; Alshammari F; Khafagy ES; Ibrahim TS; Hegazy WAH
    Pathogens; 2022 Jan; 11(1):. PubMed ID: 35056005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19.
    Alexander J; Tinkov A; Strand TA; Alehagen U; Skalny A; Aaseth J
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32784601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can Zn Be a Critical Element in COVID-19 Treatment?
    Rahman MT; Idid SZ
    Biol Trace Elem Res; 2021 Feb; 199(2):550-558. PubMed ID: 32458149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zinc Supplementation and Body Weight: A Systematic Review and Dose-Response Meta-analysis of Randomized Controlled Trials.
    Abdollahi S; Toupchian O; Jayedi A; Meyre D; Tam V; Soltani S
    Adv Nutr; 2020 Mar; 11(2):398-411. PubMed ID: 31504083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Zinc in Antiviral Immunity.
    Read SA; Obeid S; Ahlenstiel C; Ahlenstiel G
    Adv Nutr; 2019 Jul; 10(4):696-710. PubMed ID: 31305906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic Hepatitis C Virus Infection.
    Ko YL; Morihara D; Shibata K; Yamauchi R; Fukuda H; Kunimoto H; Takata K; Tanaka T; Inomata S; Yokoyama K; Takeyama Y; Shakado S; Sakisaka S
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zinc in Infection and Inflammation.
    Gammoh NZ; Rink L
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28629136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot study.
    Abbasinazari M; Alavian SM; Behnava B; Asgharinia M; Salimi S; Keshvari M; Mehrnoush L; Karim P
    J Clin Diagn Res; 2014 Dec; 8(12):HC16-9. PubMed ID: 25653968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Zinc and liver disease.
    Mohammad MK; Zhou Z; Cave M; Barve A; McClain CJ
    Nutr Clin Pract; 2012 Feb; 27(1):8-20. PubMed ID: 22307488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antioxidants as therapeutic agents for liver disease.
    Singal AK; Jampana SC; Weinman SA
    Liver Int; 2011 Nov; 31(10):1432-48. PubMed ID: 22093324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of selected nutrition supplements and complementary and alternative medicine in liver disease.
    Hanje AJ; Fortune B; Song M; Hill D; McClain C
    Nutr Clin Pract; 2006 Jun; 21(3):255-72. PubMed ID: 16772543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
    Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
    N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of zinc supplementation on the treatment of chronic hepatitis C patients with interferon and ribavirin.
    Ko WS; Guo CH; Hsu GS; Chiou YL; Yeh MS; Yaun SR
    Clin Biochem; 2005 Jul; 38(7):614-20. PubMed ID: 15904908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
    N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
    N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.